Zentalis Pharmaceuticals, a US cancer treatment specialist that raised $165 million in an IPO last month, has secured $20 million in funding to establish a China-based joint venture.
Tybourne Capital Management has led what is described as a Series A for Zentera Therapeutics, which is headquartered in Shanghai and will primarily focus on commercializing three cancer therapies discovered...
KKR has offered to acquire up to 9% of First Gen Corporation, a power plant operator in the Philippines, for PHP7.29 billion ($144 million).
Japan’s Beyond Next Ventures has led a JPY800 billion ($7.4 million) Series A round for local cell-based agricultural technology specialist IntegriCulture.
Chinese drug developer Jiangsu Atom Bioscience & Pharmaceutical has raised $30 million in Series B funding led by Sequoia Capital China and Hong Kong-listed Livzon Pharmaceutical Group.
Hillhouse Capital has led an extended Series A round of funding worth $50 million for Deepexi, a Chinese start-up that provides a suite of smart data services to enterprise customers.